本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MEI Pharma

2.29
+0.03001.33%
盤後2.290.00000.00%19:08 EDT
成交量:5,277.00
成交額:1.20萬
市值:1,525.79萬
市盈率:-0.48
高:2.33
開:2.23
低:2.23
收:2.26
資料載入中...
2023/09/29

SEC問詢函

Form CORRESP - Correspondence
2023/09/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/09/26

重要事件披露

Form 8-K - Current report
2023/09/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/18

SEC問詢函

Form CORRESP - Correspondence
2023/09/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/18

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/07/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/18

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/07/18

重要事件披露

Form 8-K - Current report
2023/07/18

重要事件披露

Form 8-K - Current report
2023/07/14

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/07/14

重要事件披露

Form 8-K - Current report
2023/07/08

重要事件披露

Form 8-K - Current report